Eli Lilly (LLY) vs Microsoft (MSFT)
A structured, side-by-side research starting point for Eli Lilly and Microsoft — price history, key metrics, and the questions great investors would ask about each. Educational only.
Price Charts
Eli LillyLLY · NYSE
以表格查看近期價格
| 日期 | 收盘价 |
|---|---|
| 2026-11-09 | $1411.95 |
| 2026-11-06 | $1354.00 |
| 2026-11-05 | $1364.73 |
| 2026-11-04 | $1417.99 |
| 2026-11-03 | $1409.38 |
| 2026-11-02 | $1410.99 |
| 2026-10-30 | $1417.54 |
| 2026-10-29 | $1373.70 |
| 2026-10-28 | $1288.30 |
| 2026-10-27 | $1281.91 |
MicrosoftMSFT · NASDAQ
以表格查看近期價格
| 日期 | 收盘价 |
|---|---|
| 2026-11-09 | $545.18 |
| 2026-11-06 | $530.61 |
| 2026-11-05 | $535.93 |
| 2026-11-04 | $555.80 |
| 2026-11-03 | $520.99 |
| 2026-11-02 | $507.12 |
| 2026-10-30 | $521.91 |
| 2026-10-29 | $530.14 |
| 2026-10-28 | $531.01 |
| 2026-10-27 | $531.33 |
Key Metrics, Side by Side
| Metric | LLY | MSFT |
|---|---|---|
| Sector | Pharmaceuticals | Software & Cloud |
| Listed | NYSE | NASDAQ |
| Business mix | Diabetes, Obesity, Oncology, Immunology | Azure, Microsoft 365, Gaming, LinkedIn |
| Moat type | Patents + pipeline + manufacturing | Switching costs + enterprise scale |
| Typical valuation profile | High growth, premium multiple | Premium quality compounder |
| Capital returns | Growing dividend + buybacks | Growing dividend + buybacks |
Approximate reference figures for education. Always verify against the latest filings before any decision.
How the Masters Would Frame Each
The same investing lenses, applied to both companies. Use them as a checklist — not as buy or sell signals.
Eli Lilly (LLY)
| Investor | Key question |
|---|---|
| Warren Buffett | How durable are the patents and franchises, and what happens at patent expiry? |
| Peter Lynch | Does the GLP-1 growth story justify a premium multiple? |
| Howard Marks | How much obesity-drug optimism is already priced in? |
| Benjamin Graham | What protection exists if pipeline trials disappoint or competition intensifies? |
Microsoft (MSFT)
| Investor | Key question |
|---|---|
| Warren Buffett | How sticky is enterprise software, and how predictable are cloud cash flows a decade out? |
| Charlie Munger | Is this a wonderful business, and is the price sensible for that quality? |
| Peter Lynch | Does Azure and AI growth justify the multiple I am paying? |
| Benjamin Graham | If cloud growth decelerates, does the current price leave room for error? |
More Comparisons
Not financial advice
This page is an educational research starting point built from public information. It is not investment advice, not a recommendation to buy or sell, and figures may be delayed or approximate. Always do your own research.
Compare any two stocks with master frameworks inside the app:
Get the App